Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1981 1
1982 2
1983 1
1985 1
1986 6
1987 3
1988 7
1989 8
1990 4
1991 3
1992 5
1993 10
1994 8
1995 12
1996 4
1997 4
1998 4
1999 3
2000 6
2001 8
2002 7
2003 9
2004 7
2005 9
2006 10
2007 6
2008 7
2009 9
2010 20
2011 13
2012 15
2013 14
2014 8
2015 11
2016 10
2017 13
2018 8
2019 9
2020 12
2021 6
2022 9
2023 13
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

303 results

Results by year

Filters applied: . Clear all
Page 1
Management of neurofibromatosis type 1-associated plexiform neurofibromas.
Fisher MJ, Blakeley JO, Weiss BD, Dombi E, Ahlawat S, Akshintala S, Belzberg AJ, Bornhorst M, Bredella MA, Cai W, Ferner RE, Gross AM, Harris GJ, Listernick R, Ly I, Martin S, Mautner VF, Salamon JM, Salerno KE, Spinner RJ, Staedtke V, Ullrich NJ, Upadhyaya M, Wolters PL, Yohay K, Widemann BC. Fisher MJ, et al. Among authors: ferner re. Neuro Oncol. 2022 Nov 2;24(11):1827-1844. doi: 10.1093/neuonc/noac146. Neuro Oncol. 2022. PMID: 35657359 Free PMC article. Review.
Biomarkers-A General Review.
Aronson JK, Ferner RE. Aronson JK, et al. Among authors: ferner re. Curr Protoc Pharmacol. 2017 Mar 17;76:9.23.1-9.23.17. doi: 10.1002/cpph.19. Curr Protoc Pharmacol. 2017. PMID: 28306150 Review.
Neurofibromatosis type 1.
Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ. Gutmann DH, et al. Among authors: ferner re. Nat Rev Dis Primers. 2017 Feb 23;3:17004. doi: 10.1038/nrdp.2017.4. Nat Rev Dis Primers. 2017. PMID: 28230061 Review.
ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1.
Carton C, Evans DG, Blanco I, Friedrich RE, Ferner RE, Farschtschi S, Salvador H, Azizi AA, Mautner V, Röhl C, Peltonen S, Stivaros S, Legius E, Oostenbrink R; ERN GENTURIS NF1 Tumour Management Guideline Group. Carton C, et al. Among authors: ferner re. EClinicalMedicine. 2023 Jan 13;56:101818. doi: 10.1016/j.eclinm.2022.101818. eCollection 2023 Feb. EClinicalMedicine. 2023. PMID: 36684394 Free PMC article. Review.
Remdesivir in covid-19.
Ferner RE, Aronson JK. Ferner RE, et al. BMJ. 2020 Apr 22;369:m1610. doi: 10.1136/bmj.m1610. BMJ. 2020. PMID: 32321732 No abstract available.
Prescribing biosimilars.
Aronson JK, Goldacre B, Ferner RE. Aronson JK, et al. Among authors: ferner re. BMJ. 2018 Jul 24;362:k3141. doi: 10.1136/bmj.k3141. BMJ. 2018. PMID: 30042142 No abstract available.
ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis.
Evans DG, Mostaccioli S, Pang D, Fadzil O Connor M, Pittara M, Champollion N, Wolkenstein P, Thomas N, Ferner RE, Kalamarides M, Peyre M, Papi L, Legius E, Becerra JL, King A, Duff C, Stivaros S, Blanco I. Evans DG, et al. Among authors: ferner re. Eur J Hum Genet. 2022 Jul;30(7):812-817. doi: 10.1038/s41431-022-01086-x. Epub 2022 Apr 1. Eur J Hum Genet. 2022. PMID: 35361920 Free PMC article.
303 results